Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

View source ↗

Summary

A clinical trial update on Inavolisib evaluating its effectiveness and safety in endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inavolisib (Inavolisib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer | Status: RECRUITING